Robin J. Lurvink

机构：Radboud University Nijmegen, Catharina Ziekenhuis · ORCID：0000-0002-2692-0994

发表论文 54 篇 · 总被引 1322 次 · h-index 17

代表论文

Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases (2023 · British journal of surgery · 被引 17)
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial (2023 · Annals of Surgical Oncology · 被引 12)
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II) (2024 · European Journal of Surgical Oncology · 被引 10)
Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II) (2024 · Surgical Endoscopy · 被引 8)
The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study (2023 · Cancers · 被引 8)
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade (2025 · Translational Oncology · 被引 5)